Riggs Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.73K | Sell |
200
-8
| -4% | -$389 | ﹤0.01% | 333 |
|
|
2025
Q1 | $7.08K | Sell |
208
-192
| -48% | -$6.53K | ﹤0.01% | 294 |
|
|
2024
Q4 | $15.5K | Hold |
400
| – | – | ﹤0.01% | 228 |
|
|
2024
Q3 | $18.8K | Sell |
400
-100
| -20% | -$4.7K | 0.01% | 211 |
|
|
2024
Q2 | $27K | Hold |
500
| – | – | 0.01% | 174 |
|
|
2024
Q1 | $34.1K | Buy |
500
+200
| +67% | +$13.6K | 0.01% | 158 |
|
|
2023
Q4 | $18.8K | Buy |
300
+200
| +200% | +$12.5K | 0.01% | 188 |
|
|
2023
Q3 | $4.54K | Hold |
100
| – | – | ﹤0.01% | 299 |
|
|
2023
Q2 | $5.61K | Buy |
+100
| New | +$5.61K | ﹤0.01% | 275 |
|